Structures by: Krishnan H.
Total: 14
Α-{3-[2-(Dimethylammonio)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide (sumatriptan) succinate
C14H22N3O2S1,C4H5O41
Acta Crystallographica Section E (2004) 60, 4 o618-o620
a=9.9076(9)Å b=11.2342(10)Å c=18.7010(16)Å
α=90.00° β=92.602(2)° γ=90.00°
Sumatriptan
C14H21N3O2S
Acta Crystallographica Section E (2006) 62, 3 o1086-o1088
a=6.3216(3)Å b=10.1290(5)Å c=24.1541(12)Å
α=90.00° β=96.3180(10)° γ=90.00°
Rizatriptan benzoate
C15H20N5,C7H5O2
Acta Crystallographica Section E (2007) 63, 4 o1958-o1960
a=8.7405(6)Å b=21.3242(15)Å c=22.2434(16)Å
α=90.00° β=90.00° γ=90.00°
Zolmitriptan
C16H21N3O2
Acta Crystallographica Section E (2007) 63, 4 o1774-o1776
a=9.0643(7)Å b=11.4220(9)Å c=14.6320(12)Å
α=90.00° β=90.00° γ=90.00°
Zolmitriptan.chloroform
C16H21N3O2,CHCl3
Acta Crystallographica Section E (2007) 63, 4 o1961-o1962
a=7.9987(6)Å b=12.8279(9)Å c=20.2396(14)Å
α=90.00° β=90.00° γ=90.00°
Erlotinib hemioxalate
2(C22H24N3O4),C2O42
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=7.6285(8)Å b=10.2252(10)Å c=14.6525(14)Å
α=86.076(2)° β=84.925(2)° γ=70.559(2)°
Erlotinib monohydrate
C22H23N3O4,H2O
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=9.0227(10)Å b=10.4548(11)Å c=13.2014(14)Å
α=98.705(2)° β=108.738(2)° γ=111.873(2)°
Erlotinib fumaric acid hemisolvate dihydrate
C22H23N3O4,0.5(C4H4O4),2(H2O)
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=7.967(2)Å b=13.248(4)Å c=13.745(4)Å
α=108.916(5)° β=106.673(5)° γ=101.909(5)°
(<i>S</i>)-4-{3-[2-(dimethylamino)ethyl]-1<i>H</i>-indol-5- ylmethyl}oxazolidin-2-one benzene solvate
C16H21N3O2,C6H6
Acta Crystallographica Section C (2007) 63, 7 o437-o440
a=8.6938(5)Å b=12.1331(7)Å c=19.5321(12)Å
α=90.00° β=90.00° γ=90.00°
(<i>S</i>)-4-{3-[2-(dimethylamino)ethyl]-1<i>H</i>-indol-5- ylmethyl}oxazolidin-2-one phenol solvate
C16H21N3O2,C6H6O
Acta Crystallographica Section C (2007) 63, 7 o437-o440
a=8.7618(13)Å b=19.506(3)Å c=12.1767(18)Å
α=90.00° β=91.399(2)° γ=90.00°
Eletriptan hydrobromide monohydrate
C22H27N2O2S,Br,H2O
Acta Crystallographica Section C (2008) 64, 12 o653-o656
a=9.4019(6)Å b=13.4089(8)Å c=18.0173(11)Å
α=90.00° β=90.00° γ=90.00°
Naratriptan hydrochloride
C17H26N3O2S,Cl
Acta Crystallographica Section C (2008) 64, 12 o653-o656
a=6.1914(5)Å b=12.2298(10)Å c=12.9948(11)Å
α=78.3480(10)° β=76.3380(10)° γ=86.0330(10)°
Almotriptan
C17H25N3O2S
Acta Crystallographica Section C (2008) 64, 1 o15-o17
a=20.5023(17)Å b=7.6894(6)Å c=22.8470(19)Å
α=90.00° β=104.904(2)° γ=90.00°
Almotriptan Malate
C17H26N3O2S,C4H5O5
Acta Crystallographica Section C (2008) 64, 1 o15-o17
a=7.5542(7)Å b=9.3561(9)Å c=17.3608(17)Å
α=104.081(2)° β=101.121(2)° γ=92.681(2)°